Alphatec Holdings, Inc.
ATECHealthcareNASDAQMedical Devices · Last scanned Oct 24, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Alphatec Holdings, Inc. focuses on Medical Devices services and products. Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. Valued at $1.71B, ATEC is a small-cap name in its sector. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Market Cap
$1.71B
Beta
0.78
P/E (TTM)
—
P/E (Fwd)
18.50
EPS (TTM)
$-0.72
EPS (Fwd)
$0.60
ROE
-373.4%
ROA
-3.1%
Cash
$118.7M
Total Debt
$604.0M
Free CF
$48.3M
52W Change
-33.0%
Annual Financials
Cash vs Debt
Where ATEC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, ATEC finished 8.44% above its 150-day moving average ($9.60) and 5.19% below its 200-day moving average ($10.98). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ATEC overbought or oversold?
At the October 20, 2026 close, ATEC's RSI(14) was 50.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Alphatec Holdings, Inc. carries $604.0M in total debt against $118.7M in cash reserves — debt is roughly 5.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $48.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -373.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $243.2M (2021) to $764.2M (2025), reflecting a 214% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ATEC.